112.77
Glaukos Corporation Borsa (GKOS) Ultime notizie
Q4 2024 Glaukos Corp Earnings Call Transcript - GuruFocus
Glaukos (NYSE: GKOS) CDO reports RSU tax withholding transactions - Stock Titan
Glaukos (NYSE: GKOS) CFO withholds 1,589 shares for RSU tax obligations - Stock Titan
Glaukos (GKOS) president uses 3,169 shares to cover tax withholding - Stock Titan
Glaukos (GKOS) CEO gifts 180,308 shares to family trust - Stock Titan
Glaukos Corp. Experiences Evaluation Revision Amidst Mixed Market Signals and Volatility - Markets Mojo
Cash per share of Glaukos Corp – DUS:6GJ - TradingView
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules - ChartMill
Glaukos Corporation $GKOS Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
GLAUKOS (GKOS) CDO has 5,798 shares withheld to cover RSU tax - Stock Titan
GKOS PE Ratio & Valuation, Is GKOS Overvalued - intellectia.ai
SG Americas Securities LLC Purchases 49,492 Shares of Glaukos Corporation $GKOS - MarketBeat
Why Glaukos Stock Jumped Over 20% After-Hours Today - msn.com
Alex Thurman: ‘Phenomenal Year’ for Glaukos - Orange County Business Journal
Price-Driven Insight from (GKOS) for Rule-Based Strategy - Stock Traders Daily
GKOS SEC FilingsGlaukos Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Chart Watch: Does Glaukos Corporation stock have upside surprise potential2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Glaukos breaks ground on $80M R&D, manufacturing facility in Alabama - msn.com
Glaukos (NYSE:GKOS) CFO Sells $267,321.06 in Stock - MarketBeat
Glaukos SVP Thurman sells $267k in GKOS stock - Investing.com
Glaukos SVP Thurman sells $267k in GKOS stock By Investing.com - Investing.com South Africa
Glaukos (NYSE: GKOS) president reports new stock and option grants - Stock Titan
Glaukos (NYSE: GKOS) CFO gets new equity awards and sells shares - Stock Titan
Glaukos Corporation (NYSE:GKOS): Is Breakeven Near? - 富途牛牛
Glaukos launches Epioxa, boosts growth in corneal treatments - MSN
Riverbridge Partners LLC Sells 34,475 Shares of Glaukos Corporation $GKOS - MarketBeat
Assenagon Asset Management S.A. Has $20.59 Million Stock Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos (GKOS) Is Up 5.5% After Launching Incision-Free Epioxa Therapy For KeratoconusWhat's Changed - simplywall.st
Vanguard realigns reporting; Vanguard subsidiaries to report GKOS holdings (GKOS) - Stock Titan
Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 1,521 Shares of Stock - MarketBeat
Glaukos CFO Thurman sells $160k in shares By Investing.com - Investing.com South Africa
Glaukos CFO Thurman sells $160k in shares - Investing.com
Glaukos (GKOS) CEO uses 2,744 shares to cover equity tax withholding - Stock Titan
Glaukos (GKOS) president sees 15,118 shares withheld to cover tax obligations - Stock Titan
Glaukos (NYSE: GKOS) insider plans sale of 2,511 vested shares - Stock Titan
Glaukos (NYSE: GKOS) CFO sale and tax share withholdings detailed - Stock Titan
Glaukos (GKOS) affiliate files to sell 1,521 shares after vesting - Stock Titan
Glaukos Corp Stock Faces Monthly Pressure Amid Analyst Optimism and Glaucoma Innovation Push - AD HOC NEWS
Piper Sandler reiterates Glaukos stock rating on growth outlook - Investing.com UK
Piper Sandler reiterates Glaukos stock rating on growth outlook By Investing.com - Investing.com Australia
Why is Glaukos (GKOS) down 14.7% since last earnings report? - MSN
JPMorgan Chase & Co. Has $54.65 Million Stock Position in Glaukos Corporation $GKOS - marketbeat.com
Glaukos Introduces Epioxa, Accelerating Expansion in Corneal Therapy - Bitget
Glaukos Announces Commercial Availability of Epioxa, a Transformative Innovation in Interventional Keratoconus Care - marketscreener.com
Glaukos Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments - Yahoo Finance Singapore
Glaukos (GKOS) Launches Epioxa HD for Keratoconus Treatment - GuruFocus
Glaukos Corporation (NYSE:GKOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Glaukos Announces Commercial Availability of Epioxa for Incision-Free Keratoconus Care - visionmonday.com
Glaukos SVP Thurman sells $61,968 in GKOS stock By Investing.com - Investing.com India
Navratil, Glaukos corp officer, sells $101k in GKOS stock By Investing.com - Investing.com Australia
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):